(window["webpackJsonp"]=window["webpackJsonp"]||[]).push([["chunk-75c4ae82"],{"5f84":function(e,i,t){"use strict";t("4de4"),t("a4d3"),t("e01a");var n=t("7a23"),a=t("914f"),r=t.n(a),s=Object(n["i"])("h3",null,"Relevant resources",-1),o={class:"card mb-3"},l={class:"card-body"},c={class:"card-title"},d={class:"card-text"},u={class:"card-text"},h=["href"],p={props:{road:String,phase:String},setup:function(e){var i=e,t=Object(n["P"])(i),a=t.phase,p=t.road,g=Object(n["d"])((function(){return r.a.filter((function(e){return p.value?e["phase"]===a.value&&e[p.value]:e["phase"]===a.value}))})),v=function(e){var i={factsheet:"bi-check-square",article:"bi-newspaper",infographic:"bi-image",video:"bi-camera-video",guideline:"bi-card-text"};return i[e]};return function(e,i){return Object(n["B"])(),Object(n["h"])(n["a"],null,[s,(Object(n["B"])(!0),Object(n["h"])(n["a"],null,Object(n["H"])(Object(n["Q"])(g),(function(e){return Object(n["B"])(),Object(n["h"])("div",{key:e},[Object(n["i"])("div",o,[Object(n["i"])("div",l,[Object(n["i"])("h5",c,[Object(n["k"])(Object(n["N"])(e.title)+" ",1),Object(n["i"])("i",{style:{"font-size":"2rem"},class:Object(n["t"])(v(e.type))},null,2)]),Object(n["i"])("p",d,Object(n["N"])(e.description),1),Object(n["i"])("p",u,Object(n["N"])(e.type),1),Object(n["i"])("a",{target:"_blank",class:"btn btn-primary stretched-link",href:e.url},"View",8,h)])])])})),128))],64)}}};const g=p;i["a"]=g},"72b9":function(e,i,t){"use strict";t.r(i);var n=t("7a23"),a=t("0e54"),r=t.n(a),s=t("5f84"),o={class:"container"},l={class:"row"},c={class:"col-md-6"},d=["innerHTML"],u={class:"col-md-6"},h={props:{title:String,content:String,phase:String},setup:function(e){return function(i,t){return Object(n["B"])(),Object(n["h"])("div",o,[Object(n["i"])("div",l,[Object(n["i"])("div",c,[Object(n["i"])("h1",null,Object(n["N"])(e.title),1),Object(n["i"])("div",{innerHTML:Object(n["Q"])(r.a)(e.content)},null,8,d)]),Object(n["i"])("div",u,[Object(n["l"])(s["a"],{phase:e.phase},null,8,["phase"])])])])}}};const p=h;i["default"]=p},"914f":function(e,i){e.exports=[{phase:"introduction",title:"What is gender? What is sex?",url:"https://cihr-irsc.gc.ca/e/48642.html",source:"CIHR",description:"Terminology",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"infographic"},{phase:"introduction",title:"Terminology",url:"http://genderedinnovations.stanford.edu/terms.html",source:"GI",description:"Terminology",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"factsheet"},{phase:"introduction",title:"Learning about Sex and Gender",url:"https://cihr-irsc.gc.ca/e/50003.html",source:"CIHR",description:"Describes why integrating sex and gender in health research is important",biomedical:"x",health:"X","in-vivo":null,"in-vitro":null,type:"video"},{phase:"introduction",title:"Introduction to Sex and Gender Considerations in Clinical and Epidemiological Research",url:"https://cihr-irsc.gc.ca/lms/e/cihrpolicysexgenderhumanparticipants/",source:"CIHR",description:"General introduction to sex and gender in clinical and epidemiological research at all stages of the research process + Quizes",biomedical:null,health:"x","in-vivo":null,"in-vitro":null,type:"course"},{phase:"introduction",title:"Evolutionary biology: Gender Aware Guidelines",url:"http://genderedinnovations.stanford.edu/methods/evobio.html",source:"GI",description:"Guideline for dealing with gender-biased assumption on biomedical research",biomedical:"x",health:"X","in-vivo":null,"in-vitro":null,type:"guideline"},{phase:"introduction",title:"Course 1: Sex and gender in biomedical research",url:"https://cihr-irsc.gc.ca/e/49347.html",source:"CIHR",description:"Course 1: Sex and gender in biomedical research",biomedical:null,health:"x","in-vivo":null,"in-vitro":null,type:"course"},{phase:"introduction",title:"Course 2: Sex and gender in primary data collection with human participants",url:"https://cihr-irsc.gc.ca/e/49347.html",source:"CIHR",description:"Course 2: Sex and gender in primary data collection with human participants",biomedical:null,health:"x","in-vivo":null,"in-vitro":null,type:"course"},{phase:"introduction",title:"Course 3: Sex and gender in the analysis of secondary data from human participants",url:"https://cihr-irsc.gc.ca/e/49347.html",source:"CIHR",description:"Course 3: Sex and gender in the analysis of secondary data from human participants",biomedical:null,health:"x","in-vivo":null,"in-vitro":null,type:"course"},{phase:"research-question",title:"The ethical imperative of sex and gender considerations in health research",url:"https://cihr-irsc.gc.ca/e/49932.html",source:"CIHR",description:"Overview of the aspects of research ethics that relate to sex and gender considerations",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"guideline"},{phase:"research-question",title:"Formulating Research Questions",url:"http://genderedinnovations.stanford.edu/methods/questions.html",source:"GI",description:"Formulating Research Questions",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"guideline"},{phase:"research-question",title:"Key considerations for the appropriate integration of sex as a biological variable",url:"https://cihr-irsc.gc.ca/e/documents/sgba_criteria_sex-en.pdf",source:"CIHR",description:"Key considerations for the appropriate integration of sex as a biological variable",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"factsheet"},{phase:"research-question",title:"Key considerations for the appropriate integration of gender as a social determinant of health",url:"https://cihr-irsc.gc.ca/e/documents/sgba_criteria_gender-en.pdf",source:"CIHR",description:"Key considerations for the appropriate integration of gender as a social determinant of health",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"factsheet"},{phase:"research-question",title:"Analyzing how Sex and Gender Interact",url:"http://genderedinnovations.stanford.edu/methods/how.html",source:"GI",description:"Key considerations how sex and gender can interact",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"factsheet"},{phase:"research-question",title:"Gender Impact Assessment",url:"http://genderedinnovations.stanford.edu/methods/impact.html",source:"GI",description:"Gender impact assessment: Stepwise process to evaluate potential impacts of research before research decisions are finalized.",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"guideline"},{phase:"research-question",title:"Rethinking Standards and Reference Models",url:"http://genderedinnovations.stanford.edu/methods/standards.html",source:"GI",description:"Information about rethinking standards and references models related to sex and gender",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"factsheet"},{phase:"study-population",title:"Science Fact or Science Fiction: If I include female animals, do I need to double my sample size?",url:"https://cihr-irsc.gc.ca/e/documents/igh_mythbuster_november_2018_en.pdf",source:"CIHR",description:"Information about study design and analysis when including female animals",biomedical:"x",health:null,"in-vivo":"x","in-vitro":null,type:"factsheet"},{phase:"study-population",title:"Considerations and guidance in designing equity-relevant clinical trials",url:"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460332/",source:"CIHR-Linked",description:"Considerations and guidance in designing equity-relevant clinical trials",biomedical:null,health:"x","in-vivo":null,"in-vitro":null,type:"article"},{phase:"study-population",title:"Inclusion of females does not increase variability in rodent research studies",url:"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294461/",source:"CIHR-Linked",description:"Article that dispels myths related to the inclusion of female animals in research, and considerations re: sample size",biomedical:"x",health:null,"in-vivo":"x","in-vitro":null,type:"article"},{phase:"study-population",title:"Sex and Gender Differences Research Design for Basic, Clinical, and Population Studies: Essentials for Investigators",url:"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263836/",source:"Hand Searched",description:"Article that describes considerations related to integrating sex and gender in research design at multiple stages, including section on study population and sample size",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"article"},{phase:"study-population",title:"CPATH Ethical Guidelines for Research Involving Transgender People & Communities",url:"https://cpath.ca/wp-content/uploads/2019/08/CPATH-Ethical-Guidelines-EN.pdf",source:"CIHR-Linked",description:"Guidelines for working with gender-diverse study populations",biomedical:null,health:"x","in-vivo":null,"in-vitro":null,type:"guideline"},{phase:"data-collection",title:"Sex and Gender in Surveys",url:"http://genderedinnovations.stanford.edu/methods/surveys.html",source:"GI",description:"How to ask about gender in surveys",biomedical:null,health:"x","in-vivo":null,"in-vitro":null,type:"factsheet"},{phase:"data-collection",title:"Analyzing Sex in Tissues and Cells",url:"http://genderedinnovations.stanford.edu/methods/tissues.html",source:"GI",description:"Specific methods for analyzing sex in tissue and cells",biomedical:"x",health:null,"in-vivo":null,"in-vitro":"x",type:"guideline"},{phase:"data-collection",title:"Lab Animal Research",url:"http://genderedinnovations.stanford.edu/methods/lab.html",source:"GI",description:"Specific methods for lab animal research",biomedical:"x",health:null,"in-vivo":"x","in-vitro":null,type:"guideline"},{phase:"data-collection",title:"Analyzing Sex in Biomedicine",url:"http://genderedinnovations.stanford.edu/methods/sex_biomed.html",source:"GI",description:"Specific methods for analyzing sex in biomedicine",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"guideline"},{phase:"data-collection",title:"Analyzing Gender in Health and Biomedicine",url:"http://genderedinnovations.stanford.edu/methods/gender_biomed.html",source:"GI",description:"Specific methods for analyzing gender in health and biomedicine",biomedical:null,health:"x","in-vivo":null,"in-vitro":null,type:"guideline"},{phase:"data-collection",title:"Analyzing Sex",url:"http://genderedinnovations.stanford.edu/methods/AnalyzingSex.pdf",source:"GI",description:"Steps to integrate sex analysis in all phases of research",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"guideline"},{phase:"data-collection",title:"Analyzing Gender",url:"http://genderedinnovations.stanford.edu/methods/AnalyzingGender.pdf",source:"GI",description:"Steps to integrate gender analysis in all phases of research",biomedical:null,health:"x","in-vivo":null,"in-vitro":null,type:"guideline"},{phase:"data-interpretation",title:"Sex, Gender and Knowledge Translation",url:"https://cihr-irsc.gc.ca/e/49933.html",source:"CIHR",description:"Information about how to consider sex and gender in the dissemination of research knowledge",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"guideline"},{phase:"data-interpretation",title:"Rethinking language and visual representation",url:"http://genderedinnovations.stanford.edu/methods/language.html",source:"GI",description:"Information about how language and visual representation shape our knowledge based science activities",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"factsheet"},{phase:"data-interpretation",title:"How to dissemminate results from sex sensitive studies",url:"http://genderedinnovations.stanford.edu/methods/AnalyzingSex.pdf",source:"GI",description:"Steps to integrate sex in all phases of research - section: Disseminate",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"guideline"},{phase:"data-interpretation",title:"How to dissemminate results from gender sensitive studies",url:"http://genderedinnovations.stanford.edu/methods/AnalyzingGender.pdf",source:"GI",description:"Steps to integrate gender in all phases of research - section: Disseminate",biomedical:null,health:"x","in-vivo":null,"in-vitro":null,type:"guideline"},{phase:"data-interpretation",title:"Why sex and gender matter in implementation research",url:"https://pubmed.ncbi.nlm.nih.gov/27788671/",source:"CIHR-Linked",description:"Article on taking a sex and gender lens in implementation research (translation of results to practice)",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"article"},{phase:"data-interpretation",title:"Sex as a biological variable: A primer",url:"https://orwh.od.nih.gov/career-development-education/e-learning/sabv-primer",source:"Hand Searched",description:"Series of courses about sex as a biological variable at various stages of the research process. For Data Interpretation and Translation, see course 4 specifically.",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"course"},{phase:"funding",title:"Rethinking Research Priorities and Outcomes",url:"http://genderedinnovations.stanford.edu/methods/priorities.html",source:"GI",description:"Critical questions for analyzing the significance (if any) of sex and gender",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"guideline"},{phase:"funding",title:"Criteria for Evaluating the integration of sex and gender [biomedical research]",url:"https://cihr-irsc.gc.ca/e/documents/biomedical_research_guidelines-en.pdf",source:"CIHR",description:"Criteria for Evaluating the integration of sex and gender [biomedical research]",biomedical:"x",health:null,"in-vivo":"x","in-vitro":"x",type:"guideline"},{phase:"funding",title:"Criteria for evaluating the integration of sex and gender [research with human participants]",url:"https://cihr-irsc.gc.ca/e/documents/clinical_research_guidelines-en.pdf",source:"CIHR",description:"Criteria for evaluating the integration of sex and gender [research with human participants]",biomedical:null,health:"x","in-vivo":null,"in-vitro":null,type:"guideline"},{phase:"funding",title:"Checklists for stepwise integration procedures for incorporating sex and gender analysis into research",url:"http://genderedinnovations.stanford.edu/researchers.html",source:"GI",description:"Checklists for researchers, grant writers, project directors and evaluators for stepwise integration procedures for incorporating sex and gender analysis into research.",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"guideline"},{phase:"assembling-teams",title:"Best Practices in Equity, Diversity and Inclusion in Research",url:"https://www.sshrc-crsh.gc.ca/funding-financement/nfrf-fnfr/edi-eng.aspx#4_1",source:"Government of Canada",description:"Guidelines for equity in research teams",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"guideline"},{phase:"assembling-teams",title:"Opinion: Gender diversity leads to better science",url:"https://www.pnas.org/content/114/8/1740",source:"PNAS",description:"Opinion paper about gender-sensitive assembly of research teams",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"article"},{phase:"assembling-teams",title:"Equity, Diversity and Inclusion as Integral to Research and Innovation Excellence: Models for Success",url:"https://gender-summit.com/portia_web/assets/GS11NA_REPORT_EN.pdf",source:"Gender Summit Report",description:"Report regarding equity in research with specific strategies for implementing this",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"report"},{phase:"assembling-teams",title:"How the entire scientific community can confront gender bias in the workplace",url:"https://www.nature.com/articles/s41559-018-0747-4",source:"Nature",description:"Article on gender bias in research",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"article"},{phase:"case-studies",title:"Case Studies for Analyzing Sex",url:"http://genderedinnovations.stanford.edu/methods/sex.html",source:"GI",description:"Related case studies for analyzing sex",biomedical:"x",health:"x","in-vivo":null,"in-vitro":null,type:"case-study"},{phase:"case-studies",title:"Case studies for Analyzing Gender",url:"http://genderedinnovations.stanford.edu/methods/gender.html",source:"GI",description:"Related case studies for analyzing gender",biomedical:null,health:"x","in-vivo":null,"in-vitro":null,type:"case-study"}]},e01a:function(e,i,t){"use strict";var n=t("23e7"),a=t("83ab"),r=t("da84"),s=t("5135"),o=t("1626"),l=t("861d"),c=t("9bf2").f,d=t("e893"),u=r.Symbol;if(a&&o(u)&&(!("description"in u.prototype)||void 0!==u().description)){var h={},p=function(){var e=arguments.length<1||void 0===arguments[0]?void 0:String(arguments[0]),i=this instanceof p?new u(e):void 0===e?u():u(e);return""===e&&(h[i]=!0),i};d(p,u);var g=p.prototype=u.prototype;g.constructor=p;var v=g.toString,m="Symbol(test)"==String(u("test")),f=/^Symbol\((.*)\)[^)]+$/;c(g,"description",{configurable:!0,get:function(){var e=l(this)?this.valueOf():this,i=v.call(e);if(s(h,e))return"";var t=m?i.slice(7,-1):i.replace(f,"$1");return""===t?void 0:t}}),n({global:!0,forced:!0},{Symbol:p})}}}]);
//# sourceMappingURL=chunk-75c4ae82.d4866254.js.map